MedTrace Logo

Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer

NCT02745847 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-05-25

No results posted yet for this study

Summary

The safety and efficacy of re-irradiation with stereotactic body radiotherapy for relapsed pancreatic cancer will be evaluated.

Conditions

Interventions

RADIATION

Re-irradiation with SBRT

Patients previously treated with SBRT with relapsed pancreatic cancer will be re-irradiated with SBRT.

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Huo Jun Zhang, MD., PH.D · Changhai Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02745847 on ClinicalTrials.gov